These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7438714)

  • 1. Ambulant blood pressure: reproducibility and the assessment of interventions.
    Mann S; Craig MW; Balasubramanian V; Cashman PM; Raftery EB
    Clin Sci (Lond); 1980 Dec; 59(6):497-500. PubMed ID: 7438714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does placebo lower blood-pressure?
    Gould BA; Mann S; Davies AB; Altman DG; Raftery EB
    Lancet; 1981 Dec 19-26; 2(8260-61):1377-81. PubMed ID: 6118757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-hour blood pressure monitoring: evaluation of Spacelabs 5300 monitor by comparison with intra-arterial blood pressure recording in ambulant subjects.
    Casadei R; Parati G; Pomidossi G; Groppelli A; Trazzi S; Di Rienzo M; Mancia G
    J Hypertens; 1988 Oct; 6(10):797-803. PubMed ID: 3198917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.
    Caruana M; Heber M; Brigden G; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):549-53. PubMed ID: 3653223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the antihypertensive effect of atenolol with 24 h ambulatory monitoring of blood pressure.
    Floras JS; Fox P; Hassan MO; Jones JV; Sleight P; Turner KL
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():387s-389s. PubMed ID: 540457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
    Cheung DG; Gasster JL; Weber MA
    Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording.
    Fariello R; Boni E; Corda L; Cantalamessa A; Zaninelli A; Pollavini G; Alicandri C; Muiesan G
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):27-33. PubMed ID: 2006994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response.
    Ragot S; Genès N; Vaur L; Herpin D
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):632-9. PubMed ID: 10912746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the antihypertensive action of xipamide using ambulatory intra-arterial monitoring.
    Raftery EB; Melville DI; Gould BA; Mann S; Whittington JR
    Br J Clin Pharmacol; 1981 Sep; 12(3):381-5. PubMed ID: 7295468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing daytime vascular resistance with progressive hypertension in ambulant patients.
    Mehta SK; Walsh JT; Goldberg AD; Topham WS
    Am Heart J; 1987 Jan; 113(1):156-62. PubMed ID: 3799429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoramin in the hypertensive diabetic patient.
    Sood VP; Stannard M; Beastall G; Weir RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S80-3. PubMed ID: 2423805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of indoramin on exercise performance in mild hypertension.
    Bishop N; Mackintosh AF; Stoker JB; Mary DA; Linden RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S30-6. PubMed ID: 2423794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
    Luomanmäki K; Hartikainen M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a diurnal rhythm in arterial blood pressure in the evaluation of 24-hour antihypertensive therapy.
    Germanó G; Damiani S; Ciavarella M; Appolloni A; Ferrucci A; Corsi V
    Clin Cardiol; 1984 Oct; 7(10):525-35. PubMed ID: 6541538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
    Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O
    Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technique and interpretation of 24-hour blood pressure measurements].
    Kiowski W; Erne P
    Schweiz Rundsch Med Prax; 1992 Jan; 81(5):115-20. PubMed ID: 1734489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
    Favre L; Adamec R; Boxho G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S60-3. PubMed ID: 2439823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.